Diagnos Laboratorium Utama Tbk. vs Lippo General Insurance Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Lippo General Insurance Tbk. trades at Rp675 (market cap 2.03T, 300 24h volume). The key difference: Lippo General Insurance Tbk. is far larger — about 6.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 300). Which is the better fit depends on your goals.
| DGNS | LPGI | |
|---|---|---|
Market Cap | 310.75B | 2.03T |
Volume | 963.6K | 300 |
Lot | 9.64K | 3 |
Turnover | 217.67M | 202.5K |
Average Price | 225.89 | 675 |
Value | 217.67M | 202.5K |
Indicative Equilibrium Price | 226 | 675 |
Indicative Equilibrium Volume | 1K | 200 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Lippo General Insurance Tbk (the Company) was established and domiciled in Surabaya based on Notarial Deed No. 1 of Adasiah Harahap, S.H., notary in Jakarta, dated September 6, 1963, under the name of PT Asuransi Brawidjaja and was changed to PT Maskapai Asuransi Marga Pusaka based onNotarial Deed No. 46 of Misahardi Wilamarta, S.H., notary in Jakarta, subtitute notary of Adasiah Harahap, S.H., notary in Jakarta.
Read more on LPGI →